Technical Analysis for NURPF - Neuren Pharmaceutica

Grade Last Price % Change Price Change
grade B 1.005 3.08% 0.0300
NURPF closed up 3.08 percent on Friday, August 23, 2019, on 9 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NURPF trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Fell Below 50 DMA Bearish 3.08%
Stochastic Sell Signal Bearish 3.08%
Narrow Range Bar Range Contraction 3.08%
Wide Bands Range Expansion 3.08%
Overbought Stochastic Strength 3.08%

Older signals for NURPF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neuren Pharmaceuticals Limited, a biopharmaceutical company, engages in the development of therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its lead product is Trofinetide, which is in Phase II clinical trials for use in the treatment of Rett syndrome, Fragile X syndrome, moderate to severe traumatic brain injury, and concussion. The company is also developing NNZ-2591 that is in preclinical development for the treatment of various neurological disorders. In addition, it holds loan funded shares. Neuren Pharmaceuticals Limited was incorporated in 1993 and is based in Auckland, New Zealand.
RTT Medical Specialties Biopharmaceutical Organ Systems Psychiatric Diagnosis Neurological Disorders Amyotrophic Lateral Sclerosis Neurotrauma Rett Syndrome Treatment Of Various Neurological Disorders Concussion Neurodegenerative Disorders
Is NURPF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 2.73
52 Week Low 0.0004
Average Volume 2,201
200-Day Moving Average 0.8714
50-Day Moving Average 0.981
20-Day Moving Average 0.8799
10-Day Moving Average 0.9283
Average True Range 0.0578
ADX 16.67
+DI 47.8191
-DI 44.4238
Chandelier Exit (Long, 3 ATRs ) 0.8766
Chandelier Exit (Short, 3 ATRs ) 0.9134
Upper Bollinger Band 1.0492
Lower Bollinger Band 0.7106
Percent B (%b) 0.87
BandWidth 38.481646
MACD Line -0.0078
MACD Signal Line -0.0454
MACD Histogram 0.0376
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.0050
Resistance 3 (R3) 1.0050 1.0050 1.0050
Resistance 2 (R2) 1.0050 1.0050 1.0050 1.0050
Resistance 1 (R1) 1.0050 1.0050 1.0050 1.0050 1.0050
Pivot Point 1.0050 1.0050 1.0050 1.0050 1.0050
Support 1 (S1) 1.0050 1.0050 1.0050 1.0050 1.0050
Support 2 (S2) 1.0050 1.0050 1.0050 1.0050
Support 3 (S3) 1.0050 1.0050 1.0050
Support 4 (S4) 1.0050